Expression of Hepcidin and Neogenin in Colorectal Cancer

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2017 Jul 22

PMID 28730177

Citations 7

Authors

Pan Xiang-Tao

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the expression of Hepcidin and Neogenin in tissue from patients with colorectal cancer, to evaluate the relationship between Hepcidin and Neogenin with clinical features, and to study their relationship with anemia.

Methods: Immuno- histochemical method was used to detect the expression of Hepcidin and Neogenin in 62 cases of colorectal cancer. At the same time, the relationship between them and their relationship with clinical characteristics and anemia were analyzed.

Results: The expression of Hepcidin was related to T stage (P<0.05), but not with age, gender, lymph node metastasis and distant metastasis. The expression of Neogenin was not correlated with T stage and lymph node metastasis, age, gender, and distant metastasis (P>0.05). There was no significant difference in the expression of Hepcidin and Neogenin between anemia group and non-anemia group. There was no correlation between Hepcidin and Neogenin (r =-0.04, P>0.05).

Conclusion: The expression of Hepcidin in colorectal cancer was related to the T stage, and had no correlation with Neogenin. The expression of Neogenin could not be used as an objective index to reflect the biological behavior of colorectal cancer.

Citing Articles

Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer.

Wu H, Dong H, Ren S, Chen J, Zhang Y, Dai M Oncol Lett. 2023; 26(2):360.

PMID: 37545621 PMC: 10398624. DOI: 10.3892/ol.2023.13946.

Iron metabolism in colorectal cancer.

Huang L, Li W, Lu Y, Ju Q, Ouyang M Front Oncol. 2023; 13:1098501.

PMID: 36910614 PMC: 9992732. DOI: 10.3389/fonc.2023.1098501.

Colorectal cancer and the blood loss paradox.

Almilaji O, Parry S, Docherty S, Snook J Frontline Gastroenterol. 2022; 13(5):381-385.

PMID: 36051962 PMC: 9380756. DOI: 10.1136/flgastro-2021-101959.

Iron Homeostasis and Hepcidin Concentration in Patients With Acromegaly.

Krygier A, Szczepanek-Parulska E, Cieslewicz M, Wrotkowska E, Chanaj-Kaczmarek J, Ruchala M Front Endocrinol (Lausanne). 2022; 12:788247.

PMID: 35211089 PMC: 8863047. DOI: 10.3389/fendo.2021.788247.

Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.

Julian-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela M, Arslan A Am J Clin Nutr. 2021; 114(4):1408-1417.

PMID: 34258619 PMC: 8488877. DOI: 10.1093/ajcn/nqab217.

References

Ward D, Roberts K, Brookes M, Joy H, Martin A, Ismail T . Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol. 2008; 14(9):1339-45. PMC: 2693679. DOI: 10.3748/wjg.14.1339. View

Shi Y, Pan X . BMP6 and BMP4 expression in patients with cancer-related anemia and its relationship with hepcidin and s-HJV. Genet Mol Res. 2016; 15(1). DOI: 10.4238/gmr.15017130. View

Bienz M, Clevers H . Linking colorectal cancer to Wnt signaling. Cell. 2000; 103(2):311-20. DOI: 10.1016/s0092-8674(00)00122-7. View

Lee D, Lee D, Zhou L, Zhou L, Zhou Z, Xie J . Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood. 2010; 115(15):3136-45. PMC: 2858467. DOI: 10.1182/blood-2009-11-251199. View

Torti S, Torti F . Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013; 13(5):342-55. PMC: 4036554. DOI: 10.1038/nrc3495. View

Fleming R, Sly W . Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A. 2001; 98(15):8160-2. PMC: 37412. DOI: 10.1073/pnas.161296298. View

Pan X, Lu Y, Cheng X, Wang J . Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia. Curr Oncol. 2016; 23(1):e24-6. PMC: 4754065. DOI: 10.3747/co.23.2840. View

Nemeth E, Tuttle M, Powelson J, Vaughn M, Donovan A, Ward D . Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-3. DOI: 10.1126/science.1104742. View

Ukarma L, Johannes H, Beyer U, Zaug M, Osterwalder B, Scherhag A . Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients. Clin Chem. 2009; 55(7):1354-60. DOI: 10.1373/clinchem.2008.121285. View

10.

Beguin Y, Aapro M, Ludwig H, Mizzen L, Osterborg A . Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review. Crit Rev Oncol Hematol. 2013; 89(1):1-15. DOI: 10.1016/j.critrevonc.2013.10.008. View

11.

Means R . Hepcidin and cytokines in anaemia. Hematology. 2005; 9(5-6):357-62. DOI: 10.1080/10245330400018540. View

12.

Durrenberger F, Abbate V, Ma Y, Arno M, Jaiash D, Parmar A . Functional characterization of fluorescent hepcidin. Bioconjug Chem. 2013; 24(9):1527-32. DOI: 10.1021/bc400121x. View

13.

Tirnitz-Parker J, Glanfield A, Olynyk J, Ramm G . Iron and hepatic carcinogenesis. Crit Rev Oncog. 2013; 18(5):391-407. DOI: 10.1615/critrevoncog.2013007759. View

14.

Gardenghi S, Renaud T, Meloni A, Casu C, Crielaard B, Bystrom L . Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood. 2013; 123(8):1137-45. PMC: 3931188. DOI: 10.1182/blood-2013-08-521625. View

15.

Alkhateeb A, Connor J . The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta. 2013; 1836(2):245-54. DOI: 10.1016/j.bbcan.2013.07.002. View

16.

Brookes M, Boult J, Roberts K, Cooper B, Hotchin N, Matthews G . A role for iron in Wnt signalling. Oncogene. 2007; 27(7):966-75. DOI: 10.1038/sj.onc.1210711. View

17.

Gangat N, Wolanskyj A . Anemia of chronic disease. Semin Hematol. 2013; 50(3):232-8. DOI: 10.1053/j.seminhematol.2013.06.006. View

18.

Rodriguez R, Jung C, Gabayan V, Deng J, Ganz T, Nemeth E . Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun. 2014; 82(2):745-52. PMC: 3911381. DOI: 10.1128/IAI.00983-13. View

19.

VanderWall K, Daniels-Wells T, Penichet M, Lichtenstein A . Iron in multiple myeloma. Crit Rev Oncog. 2013; 18(5):449-61. PMC: 3741338. DOI: 10.1615/critrevoncog.2013007934. View

20.

Ganz T . Systemic iron homeostasis. Physiol Rev. 2013; 93(4):1721-41. DOI: 10.1152/physrev.00008.2013. View